OpenAI on March 25, 2026, sharpened the public-facing mission of its technology, announcing new leadership for its nonprofit arm and a pledge to invest at least US$1 billion over the next year in projects spanning medicine, economic opportunity, and AI safety.
The effort centers on the OpenAI Foundation, which the company is positioning as a vehicle to channel its growing resources into areas where AI could deliver broad social benefits — while also addressing the risks that increasingly powerful systems may pose.
The announcement follows a corporate restructuring unveiled in October, when OpenAI transitioned to a public benefit corporation overseen by a nonprofit parent. The shift was designed to unlock new funding while preserving its stated mission: ensuring that advanced AI benefits humanity.
New faces at the helm
As part of the expansion, Robert Kaiden has been named chief financial officer of the foundation, having joined from roles at Deloitte, X, and Inspirato. Wojciech Zaremba, a co-founder of OpenAI, will lead efforts on AI resilience, while Jacob Trefethen, formerly of Coefficient Giving, will oversee life sciences initiatives.
Healing with AI
The foundation's agenda reflects what the company describes as a dual mandate: to accelerate the benefits of AI while preparing for its disruptions.
In the near term, much of the funding will be directed toward scientific and medical research, where OpenAI sees the potential for AI to compress timelines that have historically stretched over decades. One early focus is Alzheimer's disease, where researchers hope that AI systems trained on vast biological datasets can help map disease pathways, identify biomarkers, and uncover new or repurposed treatments. The foundation also plans to support the creation of large, open scientific datasets, a longstanding bottleneck in medical research.
Beyond specific diseases, the initiative will target high-mortality and high-burden conditions that have received comparatively limited funding, with the aim of lowering the cost and risk of drug development by pairing AI researchers with domain experts.
Preparing for the unintended
At the same time, OpenAI is placing new emphasis on AI resilience, preparing society for the unintended consequences of more capable systems. Early efforts will include research into how AI affects children and adolescents, the development of safety standards for models, and work to strengthen biosecurity in the face of both natural and AI-enabled biological threats.
Workers, communities, and the AI economy
The foundation also plans to expand its focus on the economic effects of AI, an area the company acknowledges could bring both disruption and opportunity. It has begun consulting with labor groups, small businesses, economists, and policymakers to identify practical ways to support workers and communities navigating technological change.
Community-based organizations are expected to play a central role. OpenAI said it would continue funding local initiatives aimed at helping people understand and adapt to AI, building on earlier grant programs designed to support what it calls "people-first" applications of the technology.
A down payment on a larger vision
The investment is part of a broader, longer-term commitment. OpenAI has previously said it intends to direct as much as US$25 billion toward efforts related to disease research and societal resilience, with the new funding representing an initial tranche.
AI is already reshaping how people work, learn, and access care, the company said, pointing to advances in scientific discovery, personalized medicine and education, and more efficient public services. But it also acknowledged that the same technologies could introduce new risks, requiring stronger safeguards and coordination across sectors.
The foundation is expected to ramp up quickly over the coming year, with additional grants and program details to be announced as its leadership team expands and its priorities take shape.
Article edited by Jerry Chen
